101 related articles for article (PubMed ID: 7146964)
1. Serum haptoglobin: a nonspecific tumor marker for renal cell carcinoma.
Babaian RJ; Swanson DA
South Med J; 1982 Nov; 75(11):1345-8. PubMed ID: 7146964
[TBL] [Abstract][Full Text] [Related]
2. Tissue polypeptide specific antigen (TPS) as a tumor marker in renal cell carcinoma.
Chang CH; Wu HC; Yen RF; Kao A; Lin CC; Lee CC
Anticancer Res; 2002; 22(5):2949-50. PubMed ID: 12530023
[TBL] [Abstract][Full Text] [Related]
3. Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK).
Wechsel HW; Petri E; Bichler KH; Feil G
Anticancer Res; 1999; 19(4A):2583-90. PubMed ID: 10470199
[TBL] [Abstract][Full Text] [Related]
4. Serum haptoglobins: a preoperative detector of metastatic renal carcinoma.
Vickers M
J Urol; 1974 Sep; 112(3):310-2. PubMed ID: 4854259
[No Abstract] [Full Text] [Related]
5. Hormones in renal cancer.
Sufrin G; Mirand EA; Moore RH; Chu TM; Murphy GP
Trans Am Assoc Genitourin Surg; 1976; 68():115-20. PubMed ID: 1030544
[TBL] [Abstract][Full Text] [Related]
6. [Changes in serum haptoglobin in patients with renal cell carcinoma (author's transl)].
Sasaki T
Nihon Hinyokika Gakkai Zasshi; 1977 Jan; 68(1):50-8. PubMed ID: 321841
[No Abstract] [Full Text] [Related]
7. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.
Levy DA; Slaton JW; Swanson DA; Dinney CP
J Urol; 1998 Apr; 159(4):1163-7. PubMed ID: 9507823
[TBL] [Abstract][Full Text] [Related]
8. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
[TBL] [Abstract][Full Text] [Related]
9. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
10. Influence of clinical factors on the haemolysis marker haptoglobin.
Körmöczi GF; Säemann MD; Buchta C; Peck-Radosavljevic M; Mayr WR; Schwartz DW; Dunkler D; Spitzauer S; Panzer S
Eur J Clin Invest; 2006 Mar; 36(3):202-9. PubMed ID: 16506966
[TBL] [Abstract][Full Text] [Related]
11. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
12. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum-circulating RNA in patients with conventional renal cell cancer.
Feng G; Li G; Gentil-Perret A; Tostain J; Genin C
Anticancer Res; 2008; 28(1A):321-6. PubMed ID: 18383864
[TBL] [Abstract][Full Text] [Related]
14. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
15. [Serum haptoglobin and alpha-1 antitrysin levels as biological evolution markers in patients with gastric and colorectal cancer].
Kovcić V; Jelić S; Filipović I; Tomasević Z
Srp Arh Celok Lek; 1994; 122(11-12):311-3. PubMed ID: 17974404
[TBL] [Abstract][Full Text] [Related]
16. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin in renal cell carcinoma: effect of tumor size, volume grade, and stage.
Singh KJ; Singh SK; Suri A; Vijjan V; Goswami AK; Khullar M
Indian J Cancer; 2005; 42(4):197-200. PubMed ID: 16391438
[TBL] [Abstract][Full Text] [Related]
18. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
[TBL] [Abstract][Full Text] [Related]
19. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
[TBL] [Abstract][Full Text] [Related]
20. A prostate-specific antigen-like protein associated with renal cell carcinoma in women.
Clements J; Ward G; Kaushal A; Hi SI; Kennett C; Nicol D
Clin Cancer Res; 1997 Aug; 3(8):1427-31. PubMed ID: 9815828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
